Literature DB >> 28487449

Voriconazole-Induced Periostitis Deformans: A Mimicker of Hypertrophic Pulmonary Osteoarthropathy.

Karim Ladak1, Laurence Rubin2.   

Abstract

Entities:  

Keywords:  Drug Toxicity; Periostitis; Voriconazole

Mesh:

Substances:

Year:  2017        PMID: 28487449      PMCID: PMC5573518          DOI: 10.3121/cmr.2017.1357

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


× No keyword cloud information.
  5 in total

1.  Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy.

Authors:  Robert A Wermers; Kay Cooper; Raymund R Razonable; Paul J Deziel; Gary M Whitford; Walter K Kremers; Thomas P Moyer
Journal:  Clin Infect Dis       Date:  2011-01-16       Impact factor: 9.079

Review 2.  Medication-induced periostitis in lung transplant patients: periostitis deformans revisited.

Authors:  Lina Chen; Michael E Mulligan
Journal:  Skeletal Radiol       Date:  2010-07-22       Impact factor: 2.199

3.  Plasma fluoride level as a predictor of voriconazole-induced periostitis in patients with skeletal pain.

Authors:  Woo J Moon; Erica L Scheller; Anupam Suneja; Jacob A Livermore; Anurag N Malani; Varsha Moudgal; Lisa E Kerr; Eric Ferguson; David M Vandenberg
Journal:  Clin Infect Dis       Date:  2014-07-03       Impact factor: 9.079

4.  Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.

Authors:  T F Wang; T Wang; R Altman; P Eshaghian; J P Lynch; D J Ross; J A Belperio; S S Weigt; R Saggar; A Gregson; B Kubak; R Saggar
Journal:  Am J Transplant       Date:  2009-10-21       Impact factor: 8.086

5.  Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.

Authors:  Bernhard Gerber; Roman Guggenberger; David Fasler; Gayathri Nair; Markus G Manz; Georg Stussi; Urs Schanz
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

  5 in total
  1 in total

1.  Spectrum of voriconazole-associated periostitis in clinical characteristics, diagnosis and management.

Authors:  Zuojun Li; Cuifang Wu; Chunjiang Wang; Zhenzhen Deng
Journal:  Infection       Date:  2022-03-14       Impact factor: 7.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.